Sarit Faragian

Attenuation of Olanzapine-Induced Weight Gain With Reboxetine in Patients With Schizophrenia: A Double-Blind, Placebo-Controlled Study

Michael Poyurovsky, Ilanit Isaacs, Camil Fuchs et al. · American Journal of Psychiatry · 2003 · 134 citations

Functional and structural neural indices of risk aversion in obsessive–compulsive disorder (OCD)

Roee Admon, Maya Bleich‐Cohen, Ronit Weizmant et al. · Psychiatry Research Neuroimaging · 2012 · 101 citations

Psychiatry, Behavioral Neuroscience, Obsessive–compulsive Disorder +12

Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled study

Michael Poyurovsky, Camil Fuchs, Artashez Pashinian et al. · Psychopharmacology · 2007 · 77 citations

Double-blind Placebo-controlled Study, Psychiatry, Medicine +11

Comparison of Clinical Characteristics and Comorbidity in Schizophrenia Patients With and Without Obsessive-Compulsive Disorder

Michael Poyurovsky, Victoria Kriss, Gregory Weisman et al. · The Journal of Clinical Psychiatry · 2003 · 70 citations

Clinical characteristics of schizotypal-related obsessive-compulsive disorder

Michael Poyurovsky, Sarit Faragian, Artashez Pashinian et al. · Psychiatry Research · 2008 · 61 citations

Psychopathology, Psychiatry, Psychotic Disorder +7